CHRISTINE DELANEY: Open Payments
NPI 1245697291 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,065 in 99 payments from 15 companies in 2025. Trend: 2023 $644 · 2024 $1,093 · 2025 $2,065
Food & beverage: $2,065
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $528 |
| Aimmune Therapeutics, Inc. | 13 | $243 |
| Janssen Biotech, Inc. | 9 | $193 |
| PFIZER INC. | 12 | $168 |
| Ardelyx, Inc. | 11 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $142 |
| Enterra Medical, Inc. | 1 | $136 |
| Phathom Pharmaceuticals, Inc. | 5 | $115 |
| GENZYME CORPORATION | 3 | $94 |
| Madrigal Pharmaceuticals | 3 | $79 |
Products named: ZENPEP, TREMFYA, RINVOQ, SKYRIZI, IBSRELA, XIFAXAN, DUPIXENT, XELJANZ.
Industry payments across NC — which companies pay providers there.
